Key facts
- This page summarizes Stephen Gordon's Form 4 filing for TransMedics Group, Inc. (TMDX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 02 May 2023, 18:31.
Stephen Gordon - 01 May 2023 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- TMDX
- Reported as of
- 01 May 2023
- Net transaction value
- -$314,550
- SEC form
- 4
- Accepted by SEC
- 02 May 2023, 18:31:56 UTC
- Prior SEC filing
- 02 Mar 2023
- Next SEC filing
- 04 Oct 2023
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Stephen Gordon
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Stephen Gordon filed Form 4 for TransMedics Group, Inc. (TMDX) on 02 May 2023.
Change
- Previous filing in this sequence was filed on 02 Mar 2023.
- Current net transaction value: -$314,550.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TMDX
transaction
Common Stock
Options Exercise
- Transaction value
- $80,700
- Shares
- +5,000
- Change %
- +27%
- Price
- $16.14*
- Shares after
- 23,789
- Date
- 01 May 2023
- Ownership
- Direct
- Footnotes
- F1
TMDX
transaction
Common Stock
Sale
- Transaction value
- $395,250
- Shares
- -5,000
- Change %
- -21%
- Price
- $79.05
- Shares after
- 18,789
- Date
- 01 May 2023
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TMDX
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -5,000
- Change %
- -32%
- Price
- $0.000000
- Shares after
- 10,728
- Date
- 01 May 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,000
- Exercise price
- $16.14
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022.
Footnote F2
Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Footnote F3
The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 27, 2024.